Company intelligence / Profile preview

Convey Capital

Ownership: Private
Development stage: Other

Overview

Convey Capital is a healthcare-focused venture capital firm rather than a drug-development operating company. The firm was launched by Amy Belt Raimundo and Sam Brasch and is described as focused on the convergence of healthcare and technology, including digital transformation across healthcare. Its investment focus appears to center on healthtech, medtech, diagnostics, healthcare IT, and technology-enabled services, with emphasis on Series A and B companies. Based on available public information, Convey Capital does not appear to have its own therapeutic pipeline, clinical-stage assets, or proprietary drug platform.

Industry: Investors

Beyond the preview

Go deeper on Convey Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Convey Capital.

Explore the full profile